<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02877667</url>
  </required_header>
  <id_info>
    <org_study_id>Soliton 2016-001</org_study_id>
    <nct_id>NCT02877667</nct_id>
  </id_info>
  <brief_title>Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol</brief_title>
  <acronym>SOL1601</acronym>
  <official_title>Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Soliton</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MedSource LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Soliton</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study of new acoustic wave device as an accessory to laser treatment in tattoo reduction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A non-significant risk, single center, prospective device trial to evaluate the number of&#xD;
      passes of Q-Switch laser treatment that can be completed with a Q-Switch Laser alone compared&#xD;
      to use of the Soliton Planar Acoustic Wave Device System (AWD) System as an accessory to&#xD;
      Q-switched laser in tattoo reduction treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Actual">April 30, 2017</completion_date>
  <primary_completion_date type="Actual">April 19, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Demonstrate that multiple passes with Quality Switched Yag laser is safe based on assessment of Adverse Events</measure>
    <time_frame>1 day</time_frame>
    <description>Safety assessments included reported Adverse Events as a result of physician examination</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy comparison of tattoo fading of laser versus laser and Acoustic Wave Device treated tattoos .</measure>
    <time_frame>12 weeks</time_frame>
    <description>The degree of fading assessed in terms of percentage fading (1-100%) and according to the following 1 to 5 scale:&#xD;
1 = 0%;&#xD;
2 = 1-25%;&#xD;
3 = 26-49%;&#xD;
4 = 50-75%; or&#xD;
5 = 76-100%</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Tattoo</condition>
  <arm_group>
    <arm_group_label>Open label device treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Up to four passes with Q-Switched laser alternating with acoustic wave device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>planar acoustic wave device</intervention_name>
    <description>accessory to laser treatment</description>
    <arm_group_label>Open label device treatment</arm_group_label>
    <other_name>AWD</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Range of Fitzpatrick skin color scores I to III&#xD;
&#xD;
          -  Tattoo with location on arms, legs, and torso only, and accessible to AWD treatment&#xD;
             head. Black ink only. Other ink colors may be present, but areas of black only tattoo&#xD;
             should meet criteria described as: minimum 1&quot; x 3&quot; tattoo with at least 30-50%&#xD;
             consistent coverage (see fig 1).&#xD;
&#xD;
          -  Tattoo age between 1 and 20 years.&#xD;
&#xD;
          -  Professionally applied.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject is pregnant or planning to become pregnant during the duration of the study.&#xD;
&#xD;
          -  Prior tattoo removal procedures on target tattoo.&#xD;
&#xD;
          -  Self-applied or amateur tattoo.&#xD;
&#xD;
          -  Tattoo layering (additional tattoo placed over an older tattoo to hide it) on target&#xD;
             tattoo.&#xD;
&#xD;
          -  Metal or plastic implants in the area of the tattoo (pacemaker, implanted&#xD;
             defibrillator, stent, or implants in the hips, knees, elbows, etc.).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chris Capelli, MD</last_name>
    <role>Study Director</role>
    <affiliation>Soliton</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SkinCare Physicians</name>
      <address>
        <city>Chestnut Hill</city>
        <state>Massachusetts</state>
        <zip>02467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 19, 2016</study_first_submitted>
  <study_first_submitted_qc>August 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2016</study_first_posted>
  <last_update_submitted>July 27, 2020</last_update_submitted>
  <last_update_submitted_qc>July 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tattoo</keyword>
  <keyword>laser</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

